Pain Science Education and Graded Exposure for Chronic Low Back Pain

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of Chile

About this trial

Chronic low back pain can affect daily activities and may be influenced by how people understand pain, their fear of movement, and their responses to stressful or uncertain physical activities. This clinical trial will evaluate whether a 6-week program combining pain science education with graded exposure to movement is more effective than usual physical therapy for adults with chronic low back pain.

Participants will be randomly assigned to one of two groups: pain science education combined with graded exposure to movement, or usual physical therapy. The study will assess changes in pain, disability, fear of movement, and pain-related thoughts. It will also examine physiological responses to stress and muscle activity while participants perform a lifting task.

The study aims to determine whether combining education about pain with gradual exposure to feared movements can improve clinical outcomes, physiological responses to stress, and motor performance in people with chronic low back pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Men and women aged 18 to 60 years.

Diagnosis of chronic low back pain, defined as low back pain occurring every day for at least 3 months or on at least half of the days during the previous 6 -months.

Willingness to participate in the study.

Disqualifiers

Body mass index >30 kg/m².

Inability to understand study instructions.

Neurological conditions affecting the central nervous system (e.g., stroke or spinal cord injury).

Pregnancy.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pain Science Education Plus Graded Exposure

    Behavioral

    Participants will receive six 30-minute pain science education sessions over 6 weeks, including two group sessions, two individual online sessions, and two asynchronous sessions. Education will address pain neurobiology, the relationship between pain and tissue damage, pain modulation, cognitive and emotional influences on pain, neuroplasticity, self-management, and the role of movement. Participants will also receive six weekly individual, in-person graded exposure sessions. Feared or avoided functional activities will be identified and hierarchically ordered, and participants will be gradually exposed to these activities. Progression will be individualized by modifying load, speed, or range of motion.

  • Usual Physical Therapy

    Other intervention

    Participants will receive one 30-minute group educational session addressing mechanical causes of low back pain, spinal anatomy, physiology and biomechanics, self-care and ergonomics, lifting techniques, and therapeutic exercise. Participants will also receive one in-person physical therapy session per week for 6 weeks, including stretching, thermotherapy, electrotherapy, and conventional core stabilization exercises (3-4 sets of 20-30 repetitions). Participants will be instructed to perform trunk stabilization exercises at home three days per week.

Treatment groups

82 Participants
are divided into 2 treatment groups
Group A: Pain Science Education Plus Graded ExposureExperimental treatment 1 intervention
Group B: Usual Physical TherapyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain Intensity

Pain intensity will be assessed using a 100-mm Visual Analog Scale (VAS), ranging from 0 mm ("no pain") to 100 mm ("worst pain imaginable"). Higher scores indicate greater pain intensity.

Time frame
Baseline and immediately after the 6-week intervention
2

Low Back Pain-Related Disability

Disability will be assessed using the validated Spanish version of the Roland-Morris Disability Questionnaire (RMDQ). The questionnaire consists of 24 items scored as 0 or 1, resulting in a total score ranging from 0 to 24. Higher scores indicate greater low back pain-related disability.

Time frame
Baseline and immediately after the 6-week intervention

Secondary outcomes

1

Heart Rate Variability

Heart rate variability (HRV) will be assessed using time- and frequency-domain measures, including high-frequency (HF) power, low-frequency (LF) power, and the root mean square of successive differences (RMSSD). HRV will be assessed at rest and during anticipation of the lifting task.

Time frame
Baseline and immediately after the 6-week intervention
2

Skin Conductance

Skin conductance will be assessed using the MED-STORM PAIN MONITOR. The number of fluctuations in skin conductance per second (NFSC) will be recorded using electrodes placed on the palms of the hands. Skin conductance will be assessed at rest and during anticipation of the lifting task, with higher NFSC values indicating greater sympathetic reactivity.

Time frame
Baseline and immediately after the 6-week intervention
3

Trunk Muscle Co-contraction During the Lifting Task

Surface electromyography (sEMG) will be recorded from the external oblique, rectus abdominis, erector spinae, and multifidus during the lifting task. Muscle co-contraction will be calculated from the area of overlap between paired muscle activation profiles, resulting in values ranging from 0 to 1, where 1 represents complete overlap.

Time frame
Baseline and immediately after the 6-week intervention
4

Kinesiophobia

Kinesiophobia will be assessed using the Spanish version of the 11-item Tampa Scale for Kinesiophobia (TSK-11). Total scores range from 11 to 44, with higher scores indicating greater kinesiophobia.

Time frame
Baseline and immediately after the 6-week intervention

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Chile

Lead sponsor

Agencia Nacional de Investigación y Desarrollo

Collaborator

This trial is not recruiting at the moment. You can still explore other options: